Post by MPN-MATE Admin » Thu Jul 16, 2020 9:56 am
Morning all... 
For some of us here, (but hopefully not all...?), some may eventually have to travel down the path of having an Allogenic Stem Cell Transplant (ASCT), when and if it becomes necessary...
... If, and when that occurs, one of the known complications that usually plays some role is whether or not the patient suffers to adversely from what is known as Graft Versus Host Disease (GVHD). In any ASCT, there will always be a certain amount of GVHD, and that is a normal function, after an almost completely decimated Patient's 'Immune System' kicks in to fight back as it rebuilds itself while morphing into new system with the benefit of the Patient's new Donor Stem Cells etc. However, in some instances, such events can and do become quite Acute, "Our Jedi Warrior" can attest to this only too well...
Hence, the hunt has long been underway to find a method to overcome this dilemma, for many who need to undergo an ASCT.
This article discusses a new theoretical method that might assist in this procedure...
Hope you might find this is interesting as did I...
Stay safe & well...
Steve
JULY 15, 2020
Sylvester researchers identify protein target that might ease graft versus host disease
by University of Miami Leonard M. Miller School of Medicine
pink patches on skin 
Concerned after haemo. consultation
